• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Constitutive resistance to viral infection in human CD141+ dendritic cells

tetano

Editor, Senior Moderator
Sci Immunol. 2017 Jul 7;2(13). pii: eaai8071. doi: 10.1126/sciimmunol.aai8071.
[h=1]Constitutive resistance to viral infection in human CD141+ dendritic cells.[/h] Silvin A[SUP]1[/SUP], Yu CI[SUP]2,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], Lahaye X[SUP]1[/SUP], Imperatore F[SUP]5[/SUP], Brault JB[SUP]6[/SUP], Cardinaud S[SUP]7,[/SUP][SUP]8[/SUP], Becker C[SUP]9[/SUP], Kwan WH[SUP]10,[/SUP][SUP]11,[/SUP][SUP]12[/SUP], Conrad C[SUP]1[/SUP], Maurin M[SUP]1[/SUP], Goudot C[SUP]1[/SUP], Marques-Ladeira S[SUP]1[/SUP], Wang Y[SUP]2[/SUP], Pascual V[SUP]2[/SUP], Anguiano E[SUP]2[/SUP], Albrecht RA[SUP]10,[/SUP][SUP]11[/SUP], Iannacone M[SUP]13[/SUP], Garc?a-Sastre A[SUP]10,[/SUP][SUP]11,[/SUP][SUP]12[/SUP], Goud B[SUP]6[/SUP], Dalod M[SUP]5[/SUP], Moris A[SUP]7[/SUP], Merad M[SUP]14[/SUP], Palucka AK[SUP]15,[/SUP][SUP]3,[/SUP][SUP]4[/SUP], Manel N[SUP]16[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Dendritic cells (DCs) are critical for the launching of protective T cell immunity in response to viral infection. Viruses can directly infect DCs, thereby compromising their viability and suppressing their ability to activate immune responses. How DC function is maintained in light of this paradox is not understood. By analyzing the susceptibility of primary human DC subsets to viral infections, we report that CD141[SUP]+[/SUP] DCs have an innate resistance to infection by a broad range of enveloped viruses, including HIV and influenza virus. In contrast, CD1c[SUP]+[/SUP] DCs are susceptible to infection, which enables viral antigen production but impairs their immune functions and survival. The ability of CD141[SUP]+[/SUP] DCs to resist infection is conferred by RAB15, a vesicle-trafficking protein constitutively expressed in this DC subset. We show that CD141[SUP]+[/SUP] DCs rely on viral antigens produced in bystander cells to launch cross-presentation-driven T cell responses. By dissociating viral infection from antigen presentation, this mechanism protects the functional capacity of DCs to launch adaptive immunity against viral infection.
Copyright ? 2017 The Authors, some rights reserved; exclusive licensee American Association for the Advancement of Science. No claim to original U.S. Government Works.


PMID: 28783704 DOI: 10.1126/sciimmunol.aai8071
 
Back
Top Bottom